# Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

> **NCT05792735** · PHASE2 · COMPLETED · sponsor: **Shenzhen People's Hospital** · enrollment: 27 (actual)

## Conditions studied

- Locally Advanced Rectal Carcinoma

## Interventions

- **DRUG:** Cadonilimab Injection
- **RADIATION:** Short-course radiotherapy
- **DRUG:** Consolidation chemotherapy

## Key facts

- **NCT ID:** NCT05792735
- **Lead sponsor:** Shenzhen People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-11
- **Primary completion:** 2024-10-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-02-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05792735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05792735, "Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05792735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*